CX Partners
CX Partners is an Indian mid-market private-equity group focused on healthcare, financial services, consumer products and IT-enabled services. It positions itself as an involved partner, combining disciplined origination with active portfolio support and planned exit routes.
At a glance
- Founded
- 2009
- Footprint
- Delhi
- Stage
- Mid-market growth
Research profile
Read the manager in sequence.
Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.
Investment lens
CX Partners uses a mid-market growth approach across Fin services, health, consumer.
Current evidence
CX Partners’ current website reports $630 million of funds under advisory, 29 portfolio companies and two registered Category II AIFs, including CX Alternative Investment Fund 3. Current attributable evidence includes Thyrocare Technologies and Healthium Medtech, which Apax identifies as a former CX Partners investment; Fund 3’s August 2024 close is reported by Private Equity International.
Strategy
Mid-market growth
Sector focus
Fin services, health, consumer
Current signal
CX Partners’ current website reports $630 million of funds under advisory, 29 portfolio companies and two registered Category II AIFs, including CX Alternative Investment Fund 3. Current attributable evidence includes Thyrocare Technologies and Healthium Medtech, which Apax identifies as a former CX Partners investment; Fund 3’s August 2024 close is reported by Private Equity International.
Next step
Need this manager reviewed against your mandate?
Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.